Labeler
Sandoz Inc NDC Codes
Sandoz Inc lists 428 finished drug products in the FDA NDC Directory under NDC labeler codes 0781, 61314.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Lisdexamfetamine dimesylate, Hyrimoz, Phenylephrine Hydrochloride, Dexmethylphenidate Hydrochloride Extended-Release, Pomalidomide, Adalimumab, Bumetanide, Sitagliptin Phosphate, Iron Sucrose, Pyzchiva, Cyclophosphamide, Pirfenidone, Pemetrexed, Dexmedetomidine Hydrochloride In 0.9% Sodium Chloride, Sugammadex
- Active ingredients
- Adalimumab, Lisdexamfetamine dimesylate, Sitagliptin phosphate, Phenylephrine hydrochloride, Dexmethylphenidate hydrochloride, Pomalidomide, Bumetanide, Iron sucrose, Ustekinumab, Cyclophosphamide, Pirfenidone, Pemetrexed disodium
- NDC labeler codes
- 0781, 61314
- Strengths (from the 100 most recently listed products)
- Phenylephrine hydrochloride 10 mg/mL; Sitagliptin phosphate 50 mg/1; Dexmedetomidine hydrochloride 4 ug/mL; Adalimumab 10 mg/.1mL; Adalimumab 80 mg/.8mL; Adalimumab 20 mg/.2mL; Fulvestrant 50 mg/mL; Adalimumab 40 mg/.4mL; Pirfenidone 267 mg/1; Acetaminophen 10 mg/mL; Dexmethylphenidate hydrochloride 15 mg/1; Dexmethylphenidate hydrochloride 20 mg/1; Dexmethylphenidate hydrochloride 5 mg/1; Dexmethylphenidate hydrochloride 10 mg/1; Pomalidomide 3 mg/1; Pomalidomide 4 mg/1; Pomalidomide 1 mg/1; Pomalidomide 2 mg/1; Fidaxomicin 200 mg/1; Sugammadex sodium 200 mg/2mL
- Dosage forms
- Injection, Solution, Injection, Capsule, Tablet, Film coated, Capsule, Extended release, Tablet, Suspension/ drops, Injection, Solution, Concentrate, Solution/ drops, Kit, Injection, Powder, Lyophilized, For solution, Concentrate, Tablet, Coated, Injection, Powder, For solution, Injection, Powder, Lyophilized, For suspension, Aerosol, Metered
- Routes
- Oral, Intravenous, Subcutaneous, Ophthalmic, Intravitreal, Intramuscular, Parenteral, Respiratory (Inhalation), Auricular (Otic)
- Drug classes (FDA established)
- Central Nervous System Stimulant, Tumor Necrosis Factor Blocker, Parenteral Iron Replacement, Dipeptidyl Peptidase 4 Inhibitor, alpha-1 Adrenergic Agonist, Thalidomide Analog, Phosphate Binder, Loop Diuretic, Interleukin-12 Antagonist, Interleukin-23 Antagonist, Pyridone, Folate Analog Metabolic Inhibitor, Central alpha-2 Adrenergic Agonist, Aminosalicylate, Corticosteroid, Sodium-Glucose Cotransporter 2 Inhibitor, Kinase Inhibitor, Biguanide, Microtubule Inhibitor, Serotonin-4 Receptor Agonist, RANK Ligand Inhibitor, Vascular Endothelial Growth Factor Inhibitor, alpha-Adrenergic Agonist, Estrogen Receptor Antagonist, Phenothiazine, Tubulin Inhibiting Agent, Macrolide Antibacterial, Purine Antimetabolite, Proton Pump Inhibitor, Integrin Receptor Antagonist, Endothelin Receptor Antagonist, Barbiturate, Methylxanthine, Nonsteroidal Anti-inflammatory Drug, Platelet Aggregation Inhibitor, Nucleoside Metabolic Inhibitor, Prostaglandin Analog, beta-Adrenergic Blocker, Penicillin-class Antibacterial, beta Lactamase Inhibitor, beta2-Adrenergic Agonist, Carbonic Anhydrase Inhibitor, Fluoroquinolone Antibacterial
- HCPCS / J-code
- J1756 — Injection, iron sucrose, 1 mg, J0897 — Injection, denosumab, 1 mg, J0135 — Injection, adalimumab, 20 mg, J3357 — Injection, ustekinumab, for subcutaneous injection, 1 mg, J2778 — Injection, ranibizumab, 0.1 mg, J0131 — Injection, acetaminophen, 10 mg
- Package NDCs
- 142 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Dexmethylphenidate Hydrochloride Extended-Releasedexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 15 mg/1 | Capsule, Extended releaseOral | 0781-2729 | 00781-2729-31 | — |
| Dexmethylphenidate Hydrochloride Extended-Releasedexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 20 mg/1 | Capsule, Extended releaseOral | 0781-2730 | 00781-2730-31 | — |
| Dexmethylphenidate Hydrochloride Extended-Releasedexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 5 mg/1 | Capsule, Extended releaseOral | 0781-2727 | 00781-2727-31 | — |
| Dexmethylphenidate Hydrochloride Extended-Releasedexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 10 mg/1 | Capsule, Extended releaseOral | 0781-2728 | 00781-2728-31 | — |
| Pomalidomide | Pomalidomide 3 mg/1 | CapsuleOral | 0781-2366 | 00781-2366-27 | — |
| Pomalidomide | Pomalidomide 4 mg/1 | CapsuleOral | 0781-2369 | 00781-2369-27 | — |
| Pomalidomide | Pomalidomide 1 mg/1 | CapsuleOral | 0781-2354 | 00781-2354-27 | — |
| Pomalidomide | Pomalidomide 2 mg/1 | CapsuleOral | 0781-2358 | 00781-2358-27 | — |
| Fidaxomicin | Fidaxomicin 200 mg/1 | Tablet, Film coatedOral | 0781-5194 | 00781-5194-20 | — |
| Sugammadex | Sugammadex sodium 200 mg/2mL | Injection, SolutionIntravenous | 0781-3468 | 00781-3468-95 | — |
| Sugammadex | Sugammadex sodium 500 mg/5mL | Injection, SolutionIntravenous | 0781-3469 | 00781-3469-95 | — |
| Mesalamine | Mesalamine 250 mg/1 | Capsule, Extended releaseOral | 0781-2791 | 00781-2791-64 | — |
| Mesalamine | Mesalamine 500 mg/1 | Capsule, Extended releaseOral | 0781-2793 | 00781-2793-72 | — |
| Ferric Carboxymaltoseferric carboxymaltose injection | Ferric carboxymaltose 50 mg/mL | Injection, SolutionIntravenous | 0781-3542 | 00781-3542-94 | — |
| Bumetanide | Bumetanide .5 mg/1 | TabletOral | 0781-8099 | 00781-8099-0100781-8099-05 | — |
| Bumetanide | Bumetanide 1 mg/1 | TabletOral | 0781-8113 | 00781-8113-0100781-8113-05 | — |
| Bumetanide | Bumetanide 2 mg/1 | TabletOral | 0781-8160 | 00781-8160-0100781-8160-05 | — |
| fluorometholone | Fluorometholone 1 mg/mL | Suspension/ dropsOphthalmic | 0781-6187 | 00781-6187-7000781-6187-75 | — |
| Cladribine | Cladribine 10 mg/1 | TabletOral | 0781-8201 | 00781-8201-3700781-8201-5100781-8201-68+4 more | — |
| Dapagliflozin | Dapagliflozin 5 mg/1 | Tablet, Film coatedOral | 0781-5985 | 00781-5985-0100781-5985-0500781-5985-10+1 more | — |
| Dapagliflozin | Dapagliflozin 10 mg/1 | Tablet, Film coatedOral | 0781-5990 | 00781-5990-0100781-5990-0500781-5990-10+1 more | — |
| nintedanib | Nintedanib esylate 100 mg/1 | CapsuleOral | 0781-2492 | 00781-2492-60 | — |
| nintedanib | Nintedanib esylate 150 mg/1 | CapsuleOral | 0781-2495 | 00781-2495-60 | — |
| Pantoprazole Sodium I.V.pantoprazole sodium | Pantoprazole sodium 40 mg/10mL | Injection, Powder, For solutionIntravenous | 0781-3480 | 00781-3480-95 | — |
| Sitagliptin Phosphate | Sitagliptin phosphate 25 mg/1 | Tablet, Film coatedOral | 0781-5766 | 00781-5766-3100781-5766-92 | — |
| Sitagliptin Phosphate | Sitagliptin phosphate 50 mg/1 | Tablet, Film coatedOral | 0781-5768 | 00781-5768-3100781-5768-92 | — |
| Sitagliptin Phosphate | Sitagliptin phosphate 100 mg/1 | Tablet, Film coatedOral | 0781-5770 | 00781-5770-1000781-5770-3100781-5770-92 | — |
| Sitagliptin and Metformin Hydrochloride | Sitagliptin phosphate 50 mg/1; Metformin hydrochloride 500 mg/1 | Tablet, Film coatedOral | 0781-5801 | 00781-5801-0500781-5801-6000781-5801-71 | — |
| Sitagliptin and Metformin Hydrochloride | Sitagliptin phosphate 50 mg/1; Metformin hydrochloride 1000 mg/1 | Tablet, Film coatedOral | 0781-5802 | 00781-5802-6000781-5802-7100781-5802-73 | — |
| Tyrukonatalizumab-sztn | Natalizumab 300 mg/15mL | InjectionIntravenous | 61314-543 | 61314-0543-94 | — |
| Iron Sucrose | Iron sucrose 50 mg/2.5mL | InjectionIntravenous | 0781-3485 | 00781-3485-9500781-3485-96 | J1756 |
| Iron Sucrose | Iron sucrose 100 mg/5mL | InjectionIntravenous | 0781-3486 | 00781-3486-9500781-3486-96 | J1756 |
| Iron Sucrose | Iron sucrose 200 mg/10mL | InjectionIntravitreal | 0781-3487 | 00781-3487-1400781-3487-9200781-3487-94 | — |
| Lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 20 mg/1 | CapsuleOral | 0781-2476 | 00781-2476-01 | — |
| Lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 10 mg/1 | CapsuleOral | 0781-2299 | 00781-2299-01 | — |
| Lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 30 mg/1 | CapsuleOral | 0781-2477 | 00781-2477-01 | — |
| Lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 40 mg/1 | CapsuleOral | 0781-2478 | 00781-2478-01 | — |
| Lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 50 mg/1 | CapsuleOral | 0781-2479 | 00781-2479-01 | — |
| Lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 60 mg/1 | CapsuleOral | 0781-2480 | 00781-2480-01 | — |
| Lisdexamfetamine dimesylate | Lisdexamfetamine dimesylate 70 mg/1 | CapsuleOral | 0781-2481 | 00781-2481-01 | — |
| macitentan | Macitentan 10 mg/1 | Tablet, Film coatedOral | 0781-8135 | 00781-8135-31 | — |
| Eribulin Mesylate | Eribulin mesylate .5 mg/mL | InjectionIntravenous | 0781-3391 | 00781-3391-94 | — |
| Prucalopride | Prucalopride succinate 1 mg/1 | Tablet, Film coatedOral | 0781-8158 | 00781-8158-31 | — |
| Prucalopride | Prucalopride succinate 2 mg/1 | Tablet, Film coatedOral | 0781-8159 | 00781-8159-31 | — |
| Wyostdenosumab | Denosumab 120 mg/1.7mL | InjectionSubcutaneous | 61314-228 | 61314-0228-94 | J0897 |
| Jubbontidenosumab | Denosumab 60 mg/mL | InjectionSubcutaneous | 61314-240 | 61314-0240-63 | J0897 |
| Adalimumabadalimumab-adaz | Adalimumab 10 mg/.1mL | Injection, SolutionSubcutaneous | 61314-391 | 61314-0391-64 | J0135 |
| Pyzchivaustekinumab-ttwe | Ustekinumab 45 mg/.5mL | Injection, SolutionSubcutaneous | 61314-651 | 61314-0651-0161314-0651-94 | J3357 |
| Pyzchivaustekinumab-ttwe | Ustekinumab 90 mg/mL | Injection, SolutionSubcutaneous | 61314-652 | 61314-0652-01 | J3357 |
| Pyzchivaustekinumab-ttwe | Ustekinumab 130 mg/26mL | Injection, SolutionIntravenous | 61314-654 | 61314-0654-94 | — |
Sandoz Inc: common questions
- What is Sandoz Inc's NDC labeler code?
- 0781, 61314. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Sandoz Inc?
- Med-Code's HCPCS directory matches J1756, J0897, J0135, J3357, J2778, J0131 to these products. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.